Budapest, Hungary

Bela Losonczi

This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bela Losonczi. Retrieved from https://idiyas.com/inventor/bela-losonczi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bela Losonczi: Innovator in Pharmaceutical Chemistry

Introduction

Bela Losonczi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve as intermediates in drug synthesis.

Latest Patents

Losonczi holds a patent for 2,6-bis(chloromethyloxy-carbonyloxymethyl)pyridine. This invention relates to a useful intermediate in the preparation of the anti-atherosclerotic drug 2,6-bis(hydroxymethyl)pyridine bis(N-methylcarbamate), also known as pyridinolcarbamate. The compound is synthesized by reacting 2,6-bis(hydroxymethyl)pyridine with chloromethyl chloroformate in a specific organic solvent under controlled temperature conditions.

Career Highlights

He is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His work has been instrumental in advancing drug development processes, particularly in the area of cardiovascular health.

Collaborations

Losonczi has collaborated with notable colleagues such as Jozsef Toth and Mate Kovatsits. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Bela Losonczi's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…